calendar
8,462 catalysts · 6,181 phase readout · 2,275 8k filing · 390 earnings · 3 pdufa · 2 approval · 1 adcom
8,462 catalysts · 6,181 phase readout · 2,275 8k filing · 390 earnings · 3 pdufa · 2 approval · 1 adcom
Sponsor: University of Sydney. Phase: PHASE3. Conditions: Rejection; Transplant, Kidney, Rejection; Transplant, Pancreas
Sponsor: University Hospital, Basel, Switzerland. Phase: NA. Conditions: Glucose Intolerance, Obesity
Sponsor: Iuliu Hatieganu University of Medicine and Pharmacy. Phase: PHASE4. Conditions: ASA Class III/IV Patients, COPD III/IV, Age 65 and Older, Multiple Organ Failure
Sponsor: Zhejiang Provincial Tongde Hospital. Phase: NA. Conditions: Alzheimer Disease, Cognitive Dysfunction, Mild Cognitive Impairment
Sponsor: Takeda. Phase: PHASE1. Conditions: Ketamine-Induced Brain Activity Changes, Psychotic-like Symptoms
Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Metastatic Colorectal Adenocarcinoma, Stage III Colorectal Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8, Unresectable Colorectal Adenocarcinoma
Sponsor: University of Zurich. Phase: NA. Conditions: Spinal Cord Injury
Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Dysphagia
Sponsor: Oryzon Genomics S.A.. Phase: PHASE2. Conditions: Borderline Personality Disorder
Sponsor: ImmunityBio, Inc.. Phase: PHASE1. Conditions: Non-Hodgkin Lymphoma Refractory/ Relapsed
Sponsor: Centre Hospitalier Universitaire de Saint Etienne. Phase: NA. Conditions: Intensive Care Unit
Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Lymphoma, Lymphoid Hyperplasia